Ocugen (OCGN) Preferred Shares (2018 - 2024)

Ocugen's (OCGN) quarterly Preferred Shares came in at $1000.0 in Q1 2024, little changed on a QoQ basis from $1000.0 in Q4 2023.

Analysis

Ocugen (OCGN) Preferred Shares (2018 - 2024) Analysis & Trends

Ocugen (OCGN) has 4 years of Preferred Shares data on file, last reported at $1000.0 in Q1 2024.

Quarterly Preferred Shares changed N/A year-over-year to $1000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $1000.0 (changed N/A YoY) and the FY2023 annual result came in at $1000.0, changed N/A from the prior year.
Preferred Shares held at $1000.0 in Q1 2024, from $1000.0 in the prior quarter.
In the past five years, Preferred Shares ranged from a high of $5.0 million in Q4 2021 to a low of $1000.0 in Q1 2021.
A 4-year average of $834166.7 and a median of $1000.0 in 2021 frame the typical range for Preferred Shares.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	-
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
10	Ocugen	458.91 Mn	358.81 Mn	-	-

Historic Data

Download Data